Searches / Journal Of The American Academy Of Dermatology[JOURNAL]

Journal Of The American Academy Of Dermatology[JOURNAL]

Sun 200 papers
RSS

Post-discontinuation recurrence following hydroxychloroquine-induced clearance in granuloma annulare.

Salloum L, Biba U, Dewey E … +5 more , Ezzeddine FL, Gregoire S, Serwald GS, Mostaghimi A, Imadojemu S

J Am Acad Dermatol · 2026 Jun · PMID 42364772 · Publisher ↗

Abstract loading — click title to view on PubMed.

JAAD Game Changers: "Association between dermatology follow-up and melanoma survival: A population-based cohort study".

Grant-Kels JM

J Am Acad Dermatol · 2026 Jun · PMID 42364771 · Publisher ↗

Abstract loading — click title to view on PubMed.

Low Dose Long-Term Capecitabine for Refractory Field Cancerization: A Retrospective Cohort Study.

Neff H, Mortelliti C, Solomon B … +5 more , Karn E, Stump M, Ran N, Silk AW, Ruiz ES

J Am Acad Dermatol · 2026 Jun · PMID 42364769 · Publisher ↗

BACKGROUND: Topical-refractory cutaneous field cancerization is challenging to manage and distressing to patients. OBJECTIVE: Evaluate the efficacy, toxicity, and patient satisfaction of long-term, low dose capecitabine... BACKGROUND: Topical-refractory cutaneous field cancerization is challenging to manage and distressing to patients. OBJECTIVE: Evaluate the efficacy, toxicity, and patient satisfaction of long-term, low dose capecitabine for field cancerization. METHODS: A retrospective cohort and survey study was performed at a single institution of patients treated with capecitabine for cutaneous field cancerization. Wilcoxon matched-pairs signed-rank test was used to compare annual keratinocyte carcinoma (KC) surgeries pre- and post-treatment at years 1, 2 and 3. RESULTS: 20 patients were treated over 20.8 months (range 0.8 - 57.5) including 8.0 months (0 - 33.1) of intervening treatment holidays. Mean KC surgeries decreased in all years of treatment compared to the year before treatment (1-year (n=18): 3.89 pre-capecitabine to 2.94, 24% reduction, p = 0.29; 2-year (n = 11): 3.46 pre-capecitabine to 0.93, 73% reduction, p = 0.02; 3-year (n = 5): 3.00 pre-capecitabine to 2.20, 27% reduction, p >0.99). Two patients (10%) discontinued therapy due to toxicity. Of 17 patients offered the survey, 12 responded (response rate 70.6%). A majority (75.0%) felt capecitabine improved their skin lesions at least moderately and 83.3% preferred capecitabine to alternative treatments.

Dermatology Images: Congenital dermal melanocytosis.

Zhu J, Zhu Y, Lin X

J Am Acad Dermatol · 2026 Jun · PMID 42364768 · Publisher ↗

Abstract loading — click title to view on PubMed.

Response to van Rooij et al., "Clinical Context and Comparative Interpretation of Dermatologic Disease Burden in People With HIV in the Modern Antiretroviral Era".

Akiska YM, Rakhmanina N, Friedman A

J Am Acad Dermatol · 2026 Jun · PMID 42361908 · Publisher ↗

Abstract loading — click title to view on PubMed.

A Novel Utilization of Liposomal Bupivacaine in Nail Procedures.

Robinson C, Kim M, Kwak R … +1 more , Morrison BW

J Am Acad Dermatol · 2026 Jun · PMID 42361907 · Publisher ↗

Abstract loading — click title to view on PubMed.

Correspondence to Abdel Azim, Sara et al. "Sunscreens part 2: Regulation and safety". Regulatory Gaps in Sunscreen Approval: A Comparison of U.S. and Korean UV Filters.

Pak C, Nguyen M, Asoudegi D … +1 more , Tsoukas M

J Am Acad Dermatol · 2026 Jun · PMID 42361905 · Publisher ↗

Abstract loading — click title to view on PubMed.

Trends in program signaling and interview invitations for dermatology residency applications: A cross-sectional analysis from 2024 to 2026 of the ERAS specialty dashboard.

Zhou AE, Moon J, Fleshner L … +3 more , Klufas T, Grant-Kels JM, Klufas DM

J Am Acad Dermatol · 2026 Jun · PMID 42360243 · Publisher ↗

Abstract loading — click title to view on PubMed.

Response to "Clinical Potential of Antimicrobial Photodynamic Therapy".

Liu X, Fang W, Ran Y

J Am Acad Dermatol · 2026 Jun · PMID 42349794 · Publisher ↗

Abstract loading — click title to view on PubMed.

Driver mutations and tumor mutational burden impact stage IV melanoma survival.

Aflatooni S, Hubbert LRS, Khadka M … +5 more , Parker L, Lipman Z, Mhaskar R, Tsai KY, Grichnik JM

J Am Acad Dermatol · 2026 Jun · PMID 42349793 · Publisher ↗

Abstract loading — click title to view on PubMed.

Highlights from JAAD Reviews: Cracking the Code on Nail Unit Squamous Cell Carcinoma.

Lipner SR

J Am Acad Dermatol · 2026 Jun · PMID 42349792 · Publisher ↗

Abstract loading — click title to view on PubMed.

Onycho-oncology: A Useful Neologism.

Heymann WR

J Am Acad Dermatol · 2026 Jun · PMID 42349791 · Publisher ↗

Abstract loading — click title to view on PubMed.

Clinical Potential of Antimicrobial Photodynamic Therapy.

Wu G, Lin L, Sheung L … +2 more , Ho CK, Du J

J Am Acad Dermatol · 2026 Jun · PMID 42341941 · Publisher ↗

Abstract loading — click title to view on PubMed.

← Prev Page 3 of 10 Next →

About

Frequency
Sun
Papers found
200
RSS feed
Subscribe